Danielle Elizabeth Clark, FNP-C

Danielle Clark practices at Thomas Hospital in Fairhope, Alabama, part of Infirmary Health.

Danielle Clark's NPI, 1598492738, was assigned on August 8, 2022. Danielle Clark holds Alabama license 1-123831.

Danielle Clark's primary practice is Thomas Hospital, at 750 Morphy Avenue, Fairhope, AL 36532 in Baldwin County. The practice phone is (251) 928-2375.

Danielle Clark's primary practice is Thomas Hospital in Fairhope, Alabama, part of Infirmary Health. Danielle Clark is also affiliated with Baldwin Health. The medical group on file is Baldwin Health Primary and Urgent Care - Gulf Shores. Dmand AI also links Danielle Clark to 2 more hospitals, 2 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Danielle Clark practices, 7 sites in all. Vendor and product names are available with a free account.

Family is Danielle Clark's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Danielle Clark is licensed in Alabama.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, insomnia, neuropathy and pneumonia among the conditions Danielle Clark treats.

CMS data shows 241 Medicare services from Danielle Clark across 5 procedure codes in 2024, for 128 Medicare patients. Medicare paid $5,858 for them. Every service was in an office.

CMS counts 128 Medicare patients who saw Danielle Clark in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Danielle Clark's median patient age at 80, with 61% women.

In 2024, Danielle Clark wrote 785 Medicare Part D claims for 237 patients. 75% of them were for generic drugs. CMS names the drug for 455 of them, across 18 drugs with 11 or more claims each, at $70,051 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Danielle Clark for performance year 2024, reported through an alternative payment model (APM). Danielle Clark accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Danielle Clark from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $31.